Prise en charge des ostéosarcomes de l’adulte

[1]  F. Goldwasser.  La décision médicale en cas de cancer incurable , 2010 .

[2]  O. Mir,et al.  CYP3A4/5 and pharmacogenetics in patients with sarcoma. , 2007, The Lancet. Oncology.

[3]  F. Goldwasser,et al.  Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel‐induced cancer cell death both in vitro and in vivo , 2006, International journal of cancer.

[4]  F. Goldwasser,et al.  Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. , 2006, Journal of the National Cancer Institute.

[5]  S. Ferrari,et al.  Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution. , 2005, European journal of cancer.

[6]  O. Mir,et al.  Hyper-alkalinization instead of hyper-hydration for the prevention of high-dose methotrexate (HDMTX) induced nephrotoxicity in osteosarcoma patients , 2005 .

[7]  O. Mir,et al.  Concomitant administration of high-dose methotrexate (HDMTX) and ifosfamide in osteosarcoma patients: A clinico-pharmacological study , 2005 .

[8]  Olivier Soubrane,et al.  Controlling tumor growth by modulating endogenous production of reactive oxygen species. , 2005, Cancer research.

[9]  J. Blay,et al.  Standards, Options and Recommendations (SOR) for diagnosis, treatment and follow-up of osteosarcoma , 1999 .

[10]  B. Fervers,et al.  Standards, Options et Recommandations (SOR) pour le diagnostic, le traitement et la surveillance de l’ostéosarcome , 1999 .

[11]  R. Souhami,et al.  Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup , 1997, The Lancet.

[12]  I. Ramzy,et al.  Fine‐needle aspiration biopsy in the diagnosis and management of bone lesions , 1997, Cancer.

[13]  H. Mankin,et al.  The Hazards of the Biopsy, Revisited. For the Members of the Musculoskeletal Tumor Society* , 1996, The Journal of bone and joint surgery. American volume.

[14]  G. Rosen,et al.  Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma , 1976, Cancer.

[15]  M. Rouprêt,et al.  515 – Tumeurs osseuses primitives , 2009 .

[16]  J. Blay,et al.  [Standards, options and recommendations (SOR) for diagnosis, treatment and follow-up of osteosarcoma. Groupe de travail SOR]. , 1999, Bulletin du cancer.

[17]  M. Campanacci.  Bone and Soft Tissue Tumors , 1999, Springer Vienna.

[18]  D. Vanel,et al.  Orthopedic surgical pathology : diagnosis of tumors and pseudotumoral lesions of bone and joints , 1998 .

[19]  W. Becker.  Bone and Soft Tissue , 1998 .

[20]  G. Missenard.  Tumeurs osseuses primitives du sacrum et de la sacro-iliaque , 1996 .

[21]  A. Giuliano,et al.  Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.